UpHealth, Inc. (UPHL)

USD 0.0

(0.0%)

EBITDA Summary of UpHealth, Inc.

  • UpHealth, Inc.'s latest annual EBITDA in 2023 was -16.89 Million USD , up 641.2% from previous year.
  • UpHealth, Inc.'s latest quarterly EBITDA in 2024 Q1 was -4.99 Million USD , up 37.83% from previous quarter.
  • UpHealth, Inc. reported an annual EBITDA of -183.99 Million USD in 2022, up 88.43% from previous year.
  • UpHealth, Inc. reported an annual EBITDA of -305.6 Million USD in 2021, down -1630.64% from previous year.
  • UpHealth, Inc. reported a quarterly EBITDA of 5.63 Million USD for 2023 Q3, up 18.55% from previous quarter.
  • UpHealth, Inc. reported a quarterly EBITDA of 881 Thousand USD for 2023 Q4, down -84.37% from previous quarter.

Annual EBITDA Chart of UpHealth, Inc. (2023 - 2019)

Historical Annual EBITDA of UpHealth, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -16.89 Million USD 641.2%
2022 -183.99 Million USD 88.43%
2021 -305.6 Million USD -1630.64%
2020 -1.6 Million USD -68.44%
2019 -953.44 Thousand USD 0.0%

Peer EBITDA Comparison of UpHealth, Inc.

Name EBITDA EBITDA Difference
Babylon Holdings Limited -176.72 Million USD 90.44%
ETAO International Co., Ltd. -893.88 Million USD 98.11%
MedAvail Holdings, Inc. -41.76 Million USD 59.545%
Micron Solutions, Inc. -308.4 Thousand USD -5378.581%
Motus GI Holdings, Inc. -11.23 Million USD -50.454%
ThermoGenesis Holdings, Inc. -7.74 Million USD -118.295%
Titan Medical Inc. 7.51 Million USD 324.698%